Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (11)

2024

  1. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

    Clinical Cancer Research, Vol. 30, Núm. 10, pp. 2085-2096

2023

  1. Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

    The Lancet Oncology, Vol. 24, Núm. 8, pp. 913-924

  2. Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images

    npj Digital Medicine, Vol. 6, Núm. 1

2022

  1. The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients

    Journal of Pathology, Vol. 258, Núm. 4, pp. 426-436

2020

  1. Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis

    Modern Pathology, Vol. 33, Núm. 8, pp. 1458-1465

2017

  1. Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Cancer Treatment Reviews, Vol. 53, pp. 79-97

2013

  1. T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes

    Journal of Immunology, Vol. 190, Núm. 12, pp. 6694-6706

2008

  1. Immunotherapy for neurological diseases

    Clinical Immunology

1996

  1. Biochemical and Serologic Evidence for the Existence of Functionally Distinct Forms of the CD94 NK Cell Receptor

    Journal of Immunology, Vol. 157, Núm. 12, pp. 5367-5374

  2. Functional resemblance between the Ig-related NK cell receptors specific for HLA class I molecules and the CD94 C-type lectin

    Chemical Immunology, Vol. 64, pp. 116-134

1994

  1. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes

    Journal of Immunology, Vol. 152, Núm. 4, pp. 1662-1671